Related Experiment Video
Updated: Sep 20, 2025

07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
2.0K
Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
Patrick M Pilz1,2, Jennifer E Ward3, Wei-Ting Chang4,5
1Stanford Cardiovascular Institute, Stanford University School of Medicine, CA (P.M.P., E.B., R.L.).
Circulation Research
|June 9, 2022
Summary
This review evaluates animal models for heart failure with reduced ejection fraction (HFrEF). Understanding their strengths and limitations is crucial for advancing translational research and developing effective human therapies.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Animal Models
Background:
- Heart failure (HF) is a complex condition involving cardiac remodeling and impaired function, rising globally due to aging populations.
- HF encompasses conditions like systolic and diastolic dysfunction, exacerbated by comorbidities such as hypertension, diabetes, and obesity.
- Heart failure with reduced ejection fraction (HFrEF) is characterized by compromised cardiac output, with left ventricular ejection fraction typically below 40%.
Purpose of the Study:
- To review and analyze the strengths, limitations, and outcomes of current small and large animal models of HFrEF.
- To guide the selection of appropriate animal models for basic and translational research into HFrEF.
- To highlight the importance of accurately recapitulating HFrEF symptoms and pathology in preclinical models.
Main Methods:
- Systematic review of existing literature on small and large animal models of HFrEF.
- Analysis of reported outcomes, including physiological, pathological, and functional parameters.
- Evaluation of how well each model replicates human HFrEF symptoms and underlying mechanisms.
Main Results:
- No single animal model fully replicates the complexity of human HFrEF.
- Various models offer insights into specific aspects of HFrEF, such as cardiac remodeling, fibrosis, and reduced ejection fraction.
- Strengths and weaknesses vary significantly across different species and induction methods.
Conclusions:
- Careful selection of animal models based on research questions is essential for advancing HFrEF understanding.
- Continued development and refinement of HFrEF animal models are needed to improve translational success.
- Evaluating model limitations is critical for interpreting research findings and guiding future therapeutic strategies.

